ORCHID CELLMARK INC

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Certification of termination of registration of a class of securities (Section 12(g))

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

No description available

Tender offer statement by a third party (amendment)

Notification of removal from listing and/or registration on a national securities exchange

5.01,5.02

Tender offer statement by a third party (amendment)

1.01,9.01

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Material Modifications to Rights of Security Holders

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

1.01,3.03,8.01,9.01

No description available

Annual report pursuant to Section 13 or 15(d)

2.02,9.01

Submission of Matters to a Vote of Security Holders

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Annual Report Scanned (Paper)

Definitive Proxy Statement

1.01,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

5.02

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

Annual report pursuant to Section 13 or 15(d) (amendment)

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

8.01

Annual report pursuant to Section 13 or 15(d)

2.02,9.01

Regulation FD Disclosure

2.05,9.01

5.02,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

Annual Report Scanned (Paper)

Definitive Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

Letter from the SEC

Correspondence with the SEC

Annual report pursuant to Section 13 or 15(d)

Correspondence with the SEC

Letter from the SEC

No description available

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Required Information in Proxy Statement

Definitive Proxy Statement

Annual Report Scanned (Paper)

Annual report pursuant to Section 13 or 15(d)

FILED AS OF DATE: 20071113

General form for quarterly reports under Section 13 or 15(d)

Annual Report Scanned (Paper)

Definitive Proxy Statement

FILED AS OF DATE: 20061211

Definitive Proxy Statement

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Required Information in Proxy Statement

WILLIAMS NICOLE

SMITH JAMES FRANCIS

DALZIEL BRUCE D

BOLOGNA THOMAS A

Thomas William John

LABORATORY CORP OF AMERICA HOLDINGS

Hayes William B

EBERTS F SAMUEL III

LABORATORY CORP OF AMERICA HOLDINGS

van der Vaart Sandra D

Walton Andrew Scott

Boyle James T. Jr.

BOLOGNA THOMAS A

Thomas William John

LABORATORY CORP OF AMERICA HOLDINGS

SMITH JAMES FRANCIS